<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="migraine/PMC6753025/results/search/disease/results.xml">
  <result pre="compare procedural, early and long-term outcome of device closure of" exact="atrial septal defect" post="(ASD) between large ASD patients and very large ASD"/>
  <result pre="complication (0.4%) of stroke. Most common long-term minor event was" exact="migraine" post="headache (3.9%) followed by arrhythmias (1.9%) without statistical difference"/>
  <result pre="risk factors of coronary artery disease, or had history of" exact="stroke" post="or transient ischemic attack underwent coronary angiography. In case"/>
  <result pre="and TTE on the next day. Procedure- or device-related death," exact="cardiac tamponade," post="erosion, thromboembolism, stroke, complete atrioventricular (AV) block, ventricular arrhythmias"/>
  <result pre="was prescribed for 6 months, and routine prophylaxis for infectious" exact="endocarditis" post="for 6 months in cases without complication. Early complications"/>
  <result pre="presented as mean±standard deviation (range) or number (%). ASD =" exact="atrial septal defect;" post="BOD = balloon occlusive diameter; BSA = body surface"/>
  <result pre="pulmonary arterial pressure; MR = mitral regurgitation; Pul. HTN =" exact="pulmonary hypertension;" post="Qp/Qs = the ratio of pulmonary blood flow to"/>
  <result pre="to completion of hemostasis; ‡4 cases of radiofrequency ablations for" exact="atrial fibrillation" post="(n=2) and wolff-parkinson-white syndrome (n=2), 3 cases of direct"/>
  <result pre="‡4 cases of radiofrequency ablations for atrial fibrillation (n=2) and" exact="wolff-parkinson-white syndrome" post="(n=2), 3 cases of direct current cardioversions, 1 case"/>
  <result pre="*One case of device migration and 1 case of complete" exact="atrioventricular block;" post="†Two cases of device retrieval (1 of device migration"/>
  <result pre="4 cases of device closure with fenestration due to severe" exact="pulmonary hypertension" post="were excluded. All of the flow of the fenestrated"/>
  <result pre="hypertension were excluded. All of the flow of the fenestrated" exact="atrial septal defect" post="closure remained patent; §Late events were defined as adverse"/>
  <result pre="except 4 cases of closure with fenestrated devices due to" exact="pulmonary hypertension." post="The residual shunt rates of multiple defects after 6"/>
  <result pre="minor complications In our 269 patients, there was no death," exact="stroke" post="and cardiac tamponade. The overall major complication rate was"/>
  <result pre="In our 269 patients, there was no death, stroke and" exact="cardiac tamponade." post="The overall major complication rate was 1.5%, and there"/>
  <result pre="procedure, but as major complication. Table 4 Major complications of" exact="atrial septal defect" post="device closure Major complications Group 1 (n=216) Group 2"/>
  <result pre="(n=53) p value Death 0 (0.0) 0 (0.0) NS Ischemic/hemorrhagic" exact="stroke" post="0 (0.0) 0 (0.0) NS Cardiac tamponade 0 (0.0)"/>
  <result pre="1 (0.5) 0 (0.0) 0.620 Ventricular tachycardia 0 0 Complete" exact="atrioventricular block" post="1 0 NS = not significant. One patient underwent"/>
  <result pre="atrial flutter underwent successful radiofrequency ablation (RFA). Nine cases of" exact="atrial fibrillation" post="(AF) were treated as below: 4 cases were spontaneously"/>
  <result pre="or transient ischemic attack was not occurred. Two cases of" exact="migraine" post="were occurred in group 1, and one case of"/>
  <result pre="no procedure- or disease-related death, device erosion, device fracture, or" exact="cardiac tamponade" post="( Table 6). During follow-up, there was one non-cardiac"/>
  <result pre="follow-up, there was one non-cardiac death, 58-year-old female died of" exact="cholangiocarcinoma" post="3 years after the device closure. There was one"/>
  <result pre="was one (0.4%) major adverse event in our study. Middle" exact="cerebral infarction" post="was occurred 8 years after device closure in one"/>
  <result pre="Table 6 Late adverse events at least 6 months after" exact="atrial septal defect" post="device closure (n=256) Adverse event Group 1 (n=207) Group"/>
  <result pre="Follow-up duration (months) 46±32.1 (6.0–135.5) 52.5±33.1 (7.4–119.0) 0.215 AF =" exact="atrial fibrillation;" post="AT = atrial tachycardia; NS = not significant. *One"/>
  <result pre="atrial tachycardia; NS = not significant. *One patient died of" exact="cholangiocarcinoma" post="3 years after device closure; †One patient had a"/>
  <result pre="3 years after device closure; †One patient had a persistent" exact="atrial fibrillation" post="before atrial septal defect device closure, and had taken"/>
  <result pre="device closure; †One patient had a persistent atrial fibrillation before" exact="atrial septal defect" post="device closure, and had taken a warfarin. There was"/>
  <result pre="difference of minor late events in both groups. Newly developed" exact="migraine" post="headache (3.9%) was most common problem, followed by AFs"/>
  <result pre="long-term major complication was occurred, except one case (0.4%) of" exact="stroke" post="in above-mentioned patient with permanent AF. Long-term follow-up data"/>
  <result pre="reported. 20) However, a recent study focused on AF and" exact="stroke" post="showed a higher incidence rate of 11.8% after ASD"/>
  <result pre="rate of 11.8% after ASD closure and higher risk of" exact="stroke" post="even after ASD closure which was related with AF,"/>
  <result pre="article, we did not analysis of pre-existed atrial tachycardia. For" exact="migraine" post="headache, we reported 4.4% of incidence (0.7% in early"/>
  <result pre="percutaneous closure, which is compatible to a study focused on" exact="migraine" post="headache after transcathter closure of ASD and patent foramen"/>
  <result pre="focused on migraine headache after transcathter closure of ASD and" exact="patent foramen ovale." post="30) While other previous studies, which conducted all complication"/>
  <result pre="which conducted all complication in together, reported lower incidence of" exact="migraine" post="headache. Other reports supported new onset of migraine headache"/>
  <result pre="incidence of migraine headache. Other reports supported new onset of" exact="migraine" post="headache after percutaneous closure of ASD, 31) 32) whereas"/>
  <result pre="whereas percutaneous closure of ASD resulted in significant reduction of" exact="migraine" post="headache. There was gap of incidence of atrial tachycardia,"/>
  <result pre="migraine headache. There was gap of incidence of atrial tachycardia," exact="migraine" post="headache between studies focused on the complications and studies"/>
  <result pre="the comprehensive evaluation of quality of life or survey for" exact="migraine" post="headache was not obtained. Cardiopulmonary function tests were performed"/>
  <result pre="1 King TD Thompson SL Steiner C Mills NL Secundum" exact="atrial septal defect." post="Nonoperative closure during cardiac catheterization JAMA 1976 235 2506"/>
  <result pre="Amplatzer Investigators Comparison between transcatheter and surgical closure of secundum" exact="atrial septal defect" post="in children and adults: results of a multicenter nonrandomized"/>
  <result pre="J Sibinga E et al. Community use of the Amplatzer" exact="atrial septal defect" post="occluder: results of the multicenter MAGIC atrial septal defect"/>
  <result pre="Amplatzer atrial septal defect occluder: results of the multicenter MAGIC" exact="atrial septal defect" post="study Pediatr Cardiol 2009 30 240 247 19015911 8"/>
  <result pre="J Gavora P Podnar T Long-term outcome of transcatheter secundum-type" exact="atrial septal defect" post="closure using Amplatzer septal occluders J Am Coll Cardiol"/>
  <result pre="GG Kleinman CS Transesophageal echocardiographic guidance of transcatheter closure of" exact="atrial septal defect" post="Am J Cardiol 1990 66 207 213 2371953 12"/>
  <result pre="and alternative techniques for device closure of the large secundum" exact="atrial septal defect" post="Catheter Cardiovasc Interv 2004 61 131 139 14696173 15"/>
  <result pre="to provide appropriate deployment in the closure of large secundum" exact="atrial septal defect" post="using Amplatzer septal occluder in children J Invasive Cardiol"/>
  <result pre="B Short and long term complications of device closure of" exact="atrial septal defect" post="and patent foramen ovale: meta-analysis of 28,142 patients from"/>
  <result pre="M Amirghofran AA Complete heart block following transcatheter closure of" exact="atrial septal defect" post="due to growth of inflammatory tissue Pediatr Cardiol 2014"/>
  <result pre="25096905 27 Rohit MK Puri K Vadivelu R Reversible complete" exact="atrioventricular block" post="after percutaneous ASD device closure in a child &amp;lt;15"/>
  <result pre="C Olsen MS Nielsen-Kudsk JE Hjortdal VE Atrial fibrillation and" exact="stroke" post="in adult patients with atrial septal defect and the"/>
  <result pre="Hjortdal VE Atrial fibrillation and stroke in adult patients with" exact="atrial septal defect" post="and the long-term effect of closure Heart 2015 101"/>
  <result pre="of atrial tachyarrhythmia before and after percutaneous closure of secundum" exact="atrial septal defect" post="in patients over 40 years of age Zhonghua Xin"/>
  <result pre="A et al. Incidence, timing, and predictive factors of new-onset" exact="migraine" post="headache attack after transcatheter closure of atrial septal defect"/>
  <result pre="factors of new-onset migraine headache attack after transcatheter closure of" exact="atrial septal defect" post="or patent foramen ovale Am J Cardiol 2008 101"/>
  <result pre="headache attack after transcatheter closure of atrial septal defect or" exact="patent foramen ovale" post="Am J Cardiol 2008 101 688 692 18308022 31"/>
  <result pre="Migraine with aura related to the percutaneous closure of an" exact="atrial septal defect" post="Catheter Cardiovasc Interv 2003 60 540 542 14624438 32"/>
  <result pre="Thijs V Herroelen L Budts W The influence of percutaneous" exact="atrial septal defect" post="closure on the occurrence of migraine Eur Heart J"/>
  <result pre="of percutaneous atrial septal defect closure on the occurrence of" exact="migraine" post="Eur Heart J 2005 26 1533 1537 15746154 33"/>
  <result pre="normalization of right ventricular volume overload after transcatheter closure of" exact="atrial septal defect" post="in children and adults Am J Cardiol 2001 88"/>
  <result pre="S et al. Right ventricular form and function after percutaneous" exact="atrial septal defect" post="device closure J Am Coll Cardiol 2001 37 2108"/>
  <result pre="Samman A Haberer K et al. Outcomes in patients with" exact="pulmonary hypertension" post="undergoing percutaneous atrial septal defect closure Heart 2008 94"/>
  <result pre="et al. Outcomes in patients with pulmonary hypertension undergoing percutaneous" exact="atrial septal defect" post="closure Heart 2008 94 1189 1193 17932093 36 Steele"/>
  <result pre="PM Fuster V Cohen M Ritter DG McGoon DC Isolated" exact="atrial septal defect" post="with pulmonary vascular obstructive disease--long-term follow-up and prediction of"/>
 </snippets>
</snippetsTree>
